News

Every groundbreaking innovation begins with a moment of inspiration. For Joseph Nounou, founder of Auros Pharma, it was a journey fueled by curiosity, compassion, and a persistent determination to save lives. His story begins with an early interest in the heart and transforms into a mission shaped by the opioid crisis, showing how purpose-driven innovation can make a difference. 

As the opioid crisis continues to escalate, it has become clear that traditional overdose treatments, while life-saving, leave critical gaps. At Auros Pharma, we took a different approach to solving this challenge. ResPen was developed to address the root cause of overdose deaths: respiratory failure.